• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 2, 2006

View Archived Issues

Studies detail pharmacokinetics, efficacy of valopicitabine

Read More

LB-80380 safe and active in lamivudine-resistant hepatitis B infection

Read More

R-1626 safe and active in chronic hepatitis C

Read More

HCV-796 well tolerated in healthy subjects

Read More

Study reveals activity of CPG-10101 alone and with peginterferon in hepatitis C

Read More

Epratuzumab safe, effective in systemic lupus erythematosus

Read More

Pfizer presents novel orally active GnRH receptor antagonist

Read More

Genaera updates findings from phase II trials of Evizon

Read More

Positive preclinical findings for antiobesity drug candidate trodusquemine

Read More

tgAAC-09 studied for prevention of HIV in Zambia

Read More

AstraZeneca and Abraxis BioScience sign agreements for Abraxane and anesthetics

Read More

A.P. Pharma begins phase III study of APF-530

Read More

New phase II trial to evaluate INS-50589 Antiplatelet in CABG patients

Read More

Chronogen cleared to begin phase I/II study of CHGN-111 in Canada

Read More

Ilypsa grants Astellas Japanese rights to ILY-101

Read More

Oglemilast for asthma and COPD enters phase II

Read More

Pirfenidone begins phase III CAPACITY program in IPF

Read More

ImQuest inlicenses piperazine compounds from Samjin

Read More

PC-DAC:Exendin-4 data support once-weekly or less frequent dosing

Read More

ISIS-301012 reduces apoB-100 in preclinical and clinical studies

Read More

NBI-56418 shows robust treatment effect in endometriosis

Read More

Actemra filed for rheumatoid arthritis in Japan

Read More

Epogin approved for anemia in premature infants

Read More

European CHMP hands down positive opinion for Tysabri in MS

Read More

Approvable letter for Nuvigil

Read More

Myozyme receives FDA approval for Pompe disease

Read More

Research with PA-082 gives insight into the mechanism of action of partial PPARgamma agonists

Read More

Recent patents cover therapeutic agents for neurological disorders

Read More

Novel agents for treating diabetes disclosed in recent patents

Read More

Novel analgesic agents disclosed in recent Gruenenthal and Janssen patents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe